CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency
Abstract Immunodeficient mice engrafted with either normal or cancerous human cells are widely used in basic and translational research. In particular, NOD/SCID/IL2rg−/− mice can support the growth of various types of human cancer cells. However, the hairs of these mice interfere with the observatio...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f445669279734610a20d18779a5652b2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f445669279734610a20d18779a5652b2 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f445669279734610a20d18779a5652b22021-12-02T11:40:58ZCRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency10.1038/s41598-017-08337-82045-2322https://doaj.org/article/f445669279734610a20d18779a5652b22017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-08337-8https://doaj.org/toc/2045-2322Abstract Immunodeficient mice engrafted with either normal or cancerous human cells are widely used in basic and translational research. In particular, NOD/SCID/IL2rg−/− mice can support the growth of various types of human cancer cells. However, the hairs of these mice interfere with the observation and imaging of engrafted tissues. Therefore, novel hairless strains exhibiting comparable immunodeficiency would be beneficial. Recently, the CRISPR/Cas9 system has been used for efficient multiplexed genome editing. In the present study, we generated a novel strain of nude NOD/SCID/IL2rg−/− (NSIN) mice by knocking out Foxn1 from NOD/SCID/IL2rg−/− (NSI) mice using the CRISPR/Cas9 system. The NSIN mice were deficient in B, T, and NK cells and not only showed impaired T cell reconstitution and thymus regeneration after allogeneic bone marrow nucleated cell transplantation but also exhibited improved capacity to graft both leukemic and solid tumor cells compared with NSI, NOG, and NDG mice. Moreover, the NSIN mice facilitated the monitoring and in vivo imaging of both leukemia and solid tumors. Therefore, our NSIN mice provide a new platform for xenograft mouse models in basic and translational research.Xinru WeiYunxin LaiBaiheng LiLe QinYoudi XuSimiao LinSuna WangQiting WuQiubin LiangGuohua HuangQiuhua DengPentao LiuDonghai WuLiangxue LaiYao YaoPeng LiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Xinru Wei Yunxin Lai Baiheng Li Le Qin Youdi Xu Simiao Lin Suna Wang Qiting Wu Qiubin Liang Guohua Huang Qiuhua Deng Pentao Liu Donghai Wu Liangxue Lai Yao Yao Peng Li CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency |
description |
Abstract Immunodeficient mice engrafted with either normal or cancerous human cells are widely used in basic and translational research. In particular, NOD/SCID/IL2rg−/− mice can support the growth of various types of human cancer cells. However, the hairs of these mice interfere with the observation and imaging of engrafted tissues. Therefore, novel hairless strains exhibiting comparable immunodeficiency would be beneficial. Recently, the CRISPR/Cas9 system has been used for efficient multiplexed genome editing. In the present study, we generated a novel strain of nude NOD/SCID/IL2rg−/− (NSIN) mice by knocking out Foxn1 from NOD/SCID/IL2rg−/− (NSI) mice using the CRISPR/Cas9 system. The NSIN mice were deficient in B, T, and NK cells and not only showed impaired T cell reconstitution and thymus regeneration after allogeneic bone marrow nucleated cell transplantation but also exhibited improved capacity to graft both leukemic and solid tumor cells compared with NSI, NOG, and NDG mice. Moreover, the NSIN mice facilitated the monitoring and in vivo imaging of both leukemia and solid tumors. Therefore, our NSIN mice provide a new platform for xenograft mouse models in basic and translational research. |
format |
article |
author |
Xinru Wei Yunxin Lai Baiheng Li Le Qin Youdi Xu Simiao Lin Suna Wang Qiting Wu Qiubin Liang Guohua Huang Qiuhua Deng Pentao Liu Donghai Wu Liangxue Lai Yao Yao Peng Li |
author_facet |
Xinru Wei Yunxin Lai Baiheng Li Le Qin Youdi Xu Simiao Lin Suna Wang Qiting Wu Qiubin Liang Guohua Huang Qiuhua Deng Pentao Liu Donghai Wu Liangxue Lai Yao Yao Peng Li |
author_sort |
Xinru Wei |
title |
CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency |
title_short |
CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency |
title_full |
CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency |
title_fullStr |
CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency |
title_full_unstemmed |
CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency |
title_sort |
crispr/cas9-mediated deletion of foxn1 in nod/scid/il2rg−/− mice results in severe immunodeficiency |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/f445669279734610a20d18779a5652b2 |
work_keys_str_mv |
AT xinruwei crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency AT yunxinlai crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency AT baihengli crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency AT leqin crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency AT youdixu crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency AT simiaolin crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency AT sunawang crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency AT qitingwu crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency AT qiubinliang crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency AT guohuahuang crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency AT qiuhuadeng crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency AT pentaoliu crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency AT donghaiwu crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency AT liangxuelai crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency AT yaoyao crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency AT pengli crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency |
_version_ |
1718395496009039872 |